These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35528236)

  • 1. Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer.
    Tao S; Tao K; Cai X
    J Oncol; 2022; 2022():7099930. PubMed ID: 35528236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
    Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
    Front Immunol; 2022; 13():916800. PubMed ID: 35860239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors.
    Li H; Lv Z; Liu M
    Medicine (Baltimore); 2023 Oct; 102(41):e35196. PubMed ID: 37832111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer.
    Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H
    Front Genet; 2022; 13():938250. PubMed ID: 36561319
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction of a Necroptosis-Associated Long Non-Coding RNA Signature to Predict Prognosis and Immune Response in Hepatocellular Carcinoma.
    Wang W; Ye Y; Zhang X; Ye X; Liu C; Bao L
    Front Mol Biosci; 2022; 9():937979. PubMed ID: 35911976
    [No Abstract]   [Full Text] [Related]  

  • 6. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
    Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
    J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer.
    Yu Z; Lu B; Gao H; Liang R
    J Oncol; 2022; 2022():5643496. PubMed ID: 36425941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 9. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma.
    Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z
    Front Genet; 2022; 13():833928. PubMed ID: 35330731
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of Prognosis and Immunotherapy of Osteosarcoma Based on Necroptosis-Related lncRNAs.
    Wang G; Zhang X; Feng W; Wang J
    Front Genet; 2022; 13():917935. PubMed ID: 35692813
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.
    Luo J; Peng J; Xiao W; Huang S; Cao Y; Wang T; Wang X
    Front Genet; 2022; 13():984696. PubMed ID: 36092933
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptosis-related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer.
    Chen F; Yang J; Fang M; Wu Y; Su D; Sheng Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24302. PubMed ID: 35229919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
    Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
    Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Necroptosis-Related Long Noncoding RNA Immune Infiltration and Prediction of Prognosis in Patients With Colon Cancer.
    Liu L; Huang L; Chen W; Zhang G; Li Y; Wu Y; Xiong J; Jie Z
    Front Mol Biosci; 2022; 9():811269. PubMed ID: 35237659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and Prognostic Value of Necroptosis-Associated lncRNA Model in Patients with Kidney Renal Clear Cell Carcinoma.
    Gu J; He Z; Huang Y; Luan T; Chen Z; Wang J; Ding M
    Dis Markers; 2022; 2022():5204831. PubMed ID: 35664432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma.
    Mo J; Cui Z; Wang Q; Zhang W; Li J; Wu S; Qian W; Zhou C; Ma Q; Wang Z; Wu Z
    Front Genet; 2022; 13():940794. PubMed ID: 36051690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma.
    Chen M; Wu GB; Hua S; Zhao ZF; Li HJ; Luo M
    Front Genet; 2022; 13():907859. PubMed ID: 36246594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.